The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18).

Saved in:
Bibliographic Details
Title: The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18).
Authors: Strauss RW; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA, r.strauss@medunigraz.at.; Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, University College London, London, UK, r.strauss@medunigraz.at.; Department of Ophthalmology, Medical University Graz, Graz, Austria, r.strauss@medunigraz.at.; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland, r.strauss@medunigraz.at., Lang L; Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, Maryland, USA., Ho A; Doheny Eye Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Jha A; Doheny Eye Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Ip M; Doheny Eye Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Bernstein PS; Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, USA., Birch DG; Retina Foundation of the Southwest, Dallas, Texas, USA., Cideciyan AV; Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Michaelides M; Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, University College London, London, UK., Audo I; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Institut de la Vision, Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-Vingts, Centre de Référence Maladies Rares REFERET and INSERM-DGOS CIC, IHU FOReSIGHT, Paris, France., Sunness JS; Hoover Low Vision Rehabilitation Services, Greater Baltimore Medical Center and University of Maryland School of Medicine, Baltimore, Maryland, USA., Traboulsi EI; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Zrenner E; Center for Ophthalmology, Eberhard-Karls University Hospital, Tübingen, Germany., Sadda SR; Doheny Eye Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Janeschitz-Kriegl L; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.; Department of Ophthalmology, University of Basel, Basel, Switzerland., West S; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA., Kong X; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA., Scholl HPN; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.; Department of Ophthalmology, University of Basel, Basel, Switzerland.
Corporate Authors: ProgStar Study Group
Source: Ophthalmic research [Ophthalmic Res] 2024; Vol. 67 (1), pp. 435-447. Date of Electronic Publication: 2024 Jul 18.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0267442 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0259 (Electronic) Linking ISSN: 00303747 NLM ISO Abbreviation: Ophthalmic Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1423-0259
DOI:10.1159/000540028